We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
3-Cinnamoyl-4-hydroxy-6-methyl-2H-pyran-2-one ameliorates diabetic peripheral neuropathy in type 2 diabetes mellitus rats via PI3K/Akt signaling pathway.
- Authors
Xiaolei Li; Suzhao Zhang; Gengliang Zhang; Jun Yuan; Shiling Rong; Meng Wang; Jie Wu; Xiaoci Feng; Huan He; Linying Tian; Weihua Xue
- Abstract
Purpose: To investigate the curative effects of 3-cinnamoyl-4-hydroxy-6-methyl-2H-pyran-2-one (CHMP) on streptozotocin (STZ)-induced model of diabetic SD rats, and the underlying mechanism. Method: Diabetes was induced in rats using single intraperitoneal injection of STZ. Subsequently, diabetic and non-diabetic rats were randomly grouped into five experimental groups. Six weeks after the STZ-injection, the diabetic animals were orally administered test compound (CHMP) at two doses of 10 and 20 mg/kg body weight for 6 weeks. Thereafter, the rats were anesthetised, and body weight, blood sugar, and motor nerve conduction velocity (MNCV) were determined. Moreover, real time-polymerase chain reaction (RT-PCR) and western blot analysis were used to assay the expression levels of genes in PIK3/Akt pathway and Glut4. Results: Treatment of diabetic rats with CHMP significantly reduced levels of fasting blood glucose and enhanced average rat body weight, relative to diabetic control (p < 0.05). Motor nerve conduction velocity (MNCV) was remarkably increased in CHMP-treated rats (54.2 ± 2.2), when compared to the diabetic control rats (46 ± 4.1, p < 0.01). Results from RT-PCR and western blot indicated increased expressions of PI3K, Akt and IRS-1, and down regulation of GSK-3B expression in skeletal muscle. The CHMP treatment also upregulated the Glut4 expression in skeletal muscle. Conclusion: These findings show that CHMP may be beneficial in the management of diabetic neuropathy.
- Subjects
STREPTOZOTOCIN; SPRAGUE Dawley rats; RATS; TYPE 2 diabetes; DIABETIC neuropathies; PERIPHERAL neuropathy; WESTERN immunoblotting; GLYCEMIC control
- Publication
Tropical Journal of Pharmaceutical Research, 2019, Vol 18, Issue 12, p2509
- ISSN
1596-5996
- Publication type
Article
- DOI
10.4314/tjpr.v18i12.7